Funding

2013 Overall proportion of industry and non-industry

  • Industry-related income: 100%

Percentage of the highest contributor: 11,8%

2014 Overall proportion of industry and non-industry

  • Industry-related income: 100%

Percentage of the highest contributor: 41%

2015 Overall proportion of industry and non-industry

Industry-related income: 100%

Percentage of the highest contributor: 34%

2016 Overall proportion of industry and non-industry

Industry-related income: 93.71%

Percentage of the highest contributor: 56.71%

2017 Overall proportion of industry and non-industry

Industry-related income: 100%

Percentage of the highest contributor: 41.70%

2018 Overall proportion industry and non-industry

Industry

Core activities: 38,2 %

Projects: 58,9 %

Non industry: 2,9 %

Percentage of the highest contributor: 47 %

2019 Overall proportion industry and non-industry:

Industry

Core activities: 32,4 %

Projects: 48,1 %

Non industry: 19,5 %

Percentage of the overall highest contributor: 50,7 %

2020 Overall proportion industry and non-industry:

Industry funding (from Grünenthal, Boston Scientific and UP John UK Limited): 87%

Non-industry funding (from partner organizations EFIC and EFNA for joint projects and membership fees): 13%

Percentage of total highest contributor:

  • For PAE core costs and projects: 45%
  • For the grants to be awarded to BMP Grant winners: 34%

2021 Overall proportion industry and non-industry:

Industry funding (from Grünenthal, Pfizer, Janssen, Boston Scientific, Viatris, GSK): 90,9%

Non-industry funding (from partner organisations, e.g., EFIC, EFNA, university educational projects, and membership fees): 9,1%

Percentage of total highest contributor:

  • For PAE core costs and projects: 21,25%
  • For the grants to be awarded to BMP Grant winners: 78,74%